Interaction between α-synuclein and other proteins in neurodegenerative disorders. - Wikidata - wikimedia - TriplyDB

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

http://www.wikidata.org/entity/Q53324250

about

Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease Cross dimerization of amyloid-β and αsynuclein proteins in aqueous environment: a molecular dynamics simulations study.Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States.α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease Interaction between pathogenic proteins in neurodegenerative disorders.From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.Advances in electrochemical detection for study of neurodegenerative disorders.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease.

P2860

Q28542628-C40E8281-6A73-4F9A-92E1-ECCDAFAE1C84 Q34165988-2D756E35-963F-4742-B3EA-B4A240785484 Q36139579-CBF0620F-427D-4242-8DC6-BB6101DF2C21 Q36174698-91703110-9959-4B6F-B4DA-132050AA6EC1 Q37083478-E7D6DCAB-C30D-4D97-A972-54648781DF11 Q37086400-5F31035A-6736-4DBE-AE23-C94F92D736B2 Q37266166-2EF5FA4F-DEE2-409E-8C27-6E8A928262E8 Q37969262-0096E380-ECE8-4113-A08E-31F0B4262ABD Q38029575-2D41451F-99FD-419C-9516-ADC7215D56AD Q38093077-138D937F-A7AB-4664-ACCC-64E8B3780FD6 Q38258246-CBBA3AEC-6A7E-4805-B18E-E0C98EEE6B55 Q38311234-E9C96433-12D0-452C-85AD-98EB89FFD913 Q38972171-2EB1CE7C-DD56-4CEA-99DA-A9DEA4503603 Q40464051-4711373E-3BC9-421B-B81F-C4B8DBF0DCA5 Q41785479-330F2108-9D10-45CF-82FB-47A8E3B4A983 Q42509261-845C9FA4-65B0-4900-A94E-0EF03C05DF51 Q48550467-F879418C-7277-4521-85E0-70CAE3283AFF Q49562668-2E8BF153-7CF4-4600-B6AB-8FC5E6EA14D2 Q49613405-E12558C8-6233-445C-91F1-1EA9C0B6BCF9 Q51762778-F212B9FC-45C6-4671-8672-64F46981E292 Q55031216-AC92AE83-04E8-4EF1-9E7D-94BB904DA76A

P2860

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

http://www.wikidata.org/entity/Q53324250

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@en

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@nl

type

label

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@en

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@nl

prefLabel

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@en

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@nl

P1433

Q53324250-29871536-FC83-4ADC-A505-6F2E1BADCE6E

P1476

Q53324250-BC5EAE4B-E3B4-4490-A840-EA9BDEB505E0

P2093

Q53324250-F5ED8657-4E09-4D93-9A49-A0F9B597BF08

P2860

Q53324250-0467A6BF-7F2D-4E51-B536-7801FCFA4B54

Q53324250-06B1B1FD-4957-4279-81FB-8A294673DAB2

Q53324250-07E3CC92-0801-49C1-BA43-A7A2C4324C52

Q53324250-07E592B0-A59E-463B-AC65-47AF9535CD39

Q53324250-0833E450-31FD-4FEE-81C9-764B54878A7E

Q53324250-085AE085-CDF6-4FE0-8655-4B8487C9AE1A

Q53324250-0911274B-8C73-4CC7-8E71-E9C548D8BB0B

Q53324250-0AED8728-14AF-4AB4-B62C-8793F472A88E

Q53324250-0AF03EF1-DFB3-4366-A84A-592A58D34DEE

Q53324250-0BC1A967-F364-4217-BE31-F7FEAFC4DB76

P304

Q53324250-79B7916E-126B-4B14-85A7-E882CD2B4707

P31

Q53324250-5BE4DDA0-930B-4F21-8BD2-B6CF7CA77DCE

Q53324250-5CFC9A6F-0D66-4396-A271-EDBAE3AA02A1

P356

Q53324250-3ACFB72D-D8A1-41D0-B4A6-002192586F08

P407

Q53324250-4B343ABD-8DD5-4732-BAB7-EDA1F2B878DD

P478

Q53324250-E61D5049-EE8E-4097-B535-8C254DC91D0A

P577

Q53324250-D593E40E-4D18-4204-977E-3FA6C23E506C

P5875

Q53324250-8C58C932-C29F-410F-9482-198D148EFE72

P698

Q53324250-374137D4-D3A0-4D70-8B23-E6BF90F9EDDF

P921

Q53324250-03E8A46C-7DEE-41C8-92D8-487DF5A99388

Q53324250-1F127863-843C-48E7-966E-CB75B2065AE3

Q53324250-2E1B075E-44FD-42F6-85F0-68D78B2A6D0E

Q53324250-46A880D2-A3CE-4C52-A033-B49FA72D3346

Q53324250-A0256922-5C75-4E4A-84DC-6F86529CF71C

Q53324250-BA764857-17C4-4AE5-9A57-AAAE883ED581

Q53324250-CED513A9-0CDA-4D80-8D47-3CA3F2A5E75A

P932

Q53324250-A51EEEE4-1926-4073-809F-6B0EF635433F

P356

P1433

The Scientific World Journal

P1476

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

@en

P2093

Kurt A Jellinger

http://www.w3.org/2001/XMLSchema#string

P2860

Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis

Alzheimer's Disease

Interface between tauopathies and synucleinopathies: A tale of two proteins

The genetic epidemiology of neurodegenerative disease.

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease

Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro

Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat

Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells

A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions

P304

1893-1907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1100/2011/371893

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51834312

http://www.w3.org/2001/XMLSchema#string

P698

22125446

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

membrane proteins

cytoskeletal proteins

nerve tissue proteins

Parkinson disease associated proteins

P932

3217595

http://www.w3.org/2001/XMLSchema#string